Insulet PE ratio PODD

Share price divided by earnings per share over the last twelve months, since 2019.

Today, Oct 23, 2026: 27.9×
7-year median: 63.0×
Against its 7-year history: 6th; percentile: 0 is its lowest day, 100 its highest
7-year range: 24.6× to 484×
Peer median: 24.8×

Insulet's PE ratio is 27.9× as of Oct 23, 2026: a share price of $149.01 against $5.35 of earnings per share over the last twelve months.

That is below its 7-year median of 63.0×, lower than on 94% of days in the last 7 years.

Over that time it ranged from 24.6× in Oct 2026 to 484× in Jun 2019.

The median for 10 medical instruments and supplies stocks of a similar size is 24.8×.

PE ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	27.9×	24.6×	84.5×
2025	84.4×	42.6×	107×
2024	47.1×	34.4×	120×
2023	127×	90.7×	253×
2022	454×	315×	475×
2021	n/m a value too high to mean anything
2020	n/m a value too high to mean anything
2019	484×	420×	484×

Against its peers

Companies in Medical - Instruments & Supplies nearest Insulet's size, closest first, today.

Company	PE ratio
PODDInsulet	27.9×
GMEDGlobus Medical	20.8×
ALGNAlign Technology	26.9×
COOCooper Companies	20.9×
PENPenumbra	79.7×
SOLVSolventum	10.4×
MSAMSA Safety	22.7×
MMSIMerit Medical Systems	38.6×
HAEHaemonetics	58.1×
VNTVontier	14.3×
BMIBadger Meter	35.3×
Peer median	24.8×

Where Insulet ranks

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Insulet

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.